Piscopo, L.; Zampella, E.; Volpe, F.; Gaudieri, V.; Nappi, C.; Di Donna, E.; Clemente, S.; Varallo, A.; Scaglione, M.; Cuocolo, A.;
et al. The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience. Curr. Oncol. 2024, 31, 5617-5629.
https://doi.org/10.3390/curroncol31090416
AMA Style
Piscopo L, Zampella E, Volpe F, Gaudieri V, Nappi C, Di Donna E, Clemente S, Varallo A, Scaglione M, Cuocolo A,
et al. The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience. Current Oncology. 2024; 31(9):5617-5629.
https://doi.org/10.3390/curroncol31090416
Chicago/Turabian Style
Piscopo, Leandra, Emilia Zampella, Fabio Volpe, Valeria Gaudieri, Carmela Nappi, Erica Di Donna, Stefania Clemente, Antonio Varallo, Mariano Scaglione, Alberto Cuocolo,
and et al. 2024. "The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience" Current Oncology 31, no. 9: 5617-5629.
https://doi.org/10.3390/curroncol31090416
APA Style
Piscopo, L., Zampella, E., Volpe, F., Gaudieri, V., Nappi, C., Di Donna, E., Clemente, S., Varallo, A., Scaglione, M., Cuocolo, A., & Klain, M.
(2024). The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience. Current Oncology, 31(9), 5617-5629.
https://doi.org/10.3390/curroncol31090416
